Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


Former US VP Dick Cheney dies at 84
Dozens killed, army helicopter downed as Typhoon Kalmaegi hits Philippines
Trump threatens to cut funds for New York City if Mamdani wins mayoral race
Worker trapped under collapsed medieval tower in Rome dies
